Esomeprazole
NDC Package 64239-112-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Esomeprazole is a . Marketed by Dexcel Pharma Technologies Ltd, this product is identified by NDC 64239-112 and is authorized under FDA application NDA214278.

Identification & Billing

NDC Package Code
64239-112-07
Package Description
2 BLISTER PACK in 1 CARTON / 7 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
Product Code
64239-112
11-Digit Billing Format
64239011207

Clinical Specifications

Proprietary Name
Esomeprazole
Dosage Form
-

Regulatory & Marketing

Labeler Name
Dexcel Pharma Technologies Ltd
FDA Application #
NDA214278
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-12-2024
End Marketing Date
04-12-2024
Listing Expiration
04-12-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64239-112). Click a package code to view its specific billing and regulatory data.

64239-112-02
2 BLISTER PACK in 1 CARTON / 7 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
64239-112-03
2 CARTON in 1 CARTON / 2 BLISTER PACK in 1 CARTON / 7 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
64239-112-04
3 CARTON in 1 CARTON / 2 BLISTER PACK in 1 CARTON / 7 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
64239-112-05
1 BLISTER PACK in 1 CARTON / 2 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
64239-112-08
2 CARTON in 1 CARTON / 2 BLISTER PACK in 1 CARTON / 7 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
64239-112-09
3 CARTON in 1 CARTON / 2 BLISTER PACK in 1 CARTON / 7 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
64239-112-10
1 BLISTER PACK in 1 CARTON / 2 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64239-112-07 identifies a specific commercial package of 2 blister pack in 1 carton / 7 tablet, orally disintegrating, delayed release in 1 blister pack of Esomeprazole, labeled by Dexcel Pharma Technologies Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dexcel Pharma Technologies Ltd on April 12, 2024. The current certification is valid through April 12, 2024.

How is this Dexcel Pharma Technologies Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64239011207. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64239-112-07
11-Digit CMS (5-4-2)
64239-0112-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.